30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

NASS Review: Spinal Robotics, Enabling Technologies, 3D Printing and Biologics

Enabling technology was the story of the North American Spine Society 2019 annual meeting (NASS), with the top spine players heavily featuring their robotic-assisted surgery ecosystems.

MNVC to Provide Startup and Investment Forecasts from Industry Veterans and Newcomers

Twenty-two private companies developing new and emerging technologies, including hardware, biologics, software and diagnostics, are expected to provide pitches at MNVC.

ORTHOWORLD Member Success Story: Magnus René on Integrum's OPRA Prosthetics, Additive Manufacturing Adoption

Magnus René has been part of the additive manufacturing revolution in orthopedics, from initial trials in 2004 to mass production opportunities today. Now he serves on the Board of Directors for Integrum, developer of the OPRA osseointegrated prosthetic implant system for amputees–as well as next-generation robotic prostheses. He tells Integrum's story and shares his most significant professional accomplishment.

Orthopedic Public Companies Grow 2.6% YoY in Quarter

The second quarter of 2019 brought incremental improvement over the first. Stryker and Medtronic saw revenue growth in the mid-single digits, Smith & Nephew performed at 1.6% and DePuy Synthes and Zimmer Biomet experienced a year-over-year loss. Price pressure was a common theme in the quarter for many companies, as it offset some gains made from increased surgical volumes for the reporting period. 

Opportunity in Value-Based Care Lies in Impacting Quality

The mid- to long-term future will require increased evidence to support pricing and value by device companies. It can be contended that broader thinking and strategic response around quality might actually create opportunities for sustained and growing market share for OEMs, as well as greater value for customers—hospitals, physicians and patients.

Page Navigation
First